Publications
-
A dermal HOX transcriptional program regulates site-specific epidermal fate.
Rinn JL,
Wang JK, Allen N, Brugmann SA, Mikels AJ, Liu H, Ridky TW, Stadler HS, Nusse R, Helms JA, Chang HY.
Genes Dev.
2008;
22
(3):
303-7
-
Nonmelanoma skin cancer.
Ridky TW,
J Am Acad Dermatol.
2007;
57
(3):
484-501
-
p63 regulates proliferation and differentiation of developmentally mature keratinocytes.
Truong AB,
Kretz M, Ridky TW, Kimmel R, Khavari PA.
Genes Dev.
2006;
20
(22):
3185-97
-
Pathways sufficient to induce epidermal carcinogenesis.
Ridky TW,
Khavari PA.
Cell Cycle.
2004;
3
(5):
621-4
-
Eruptive xanthomas associated with olanzapine use.
Chang HY,
Ridky TW, Kimball AB, Hughes E, Oro AE.
Arch Dermatol.
2003;
139
(8):
1045-8
-
Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate.
Ridky TW,
Kikonyogo A, Leis J, Gulnik S, Copeland T, Erickson J, Wlodawer A, Kurinov I, Harrison RW, Weber IT.
Biochemistry.
1998;
37
(39):
13835-45
-
Programming the Rous sarcoma virus protease to cleave new substrate sequences.
Ridky TW,
Bizub-Bender D, Cameron CE, Weber IT, Wlodawer A, Copeland T, Skalka AM, Leis J.
J Biol Chem.
1996;
271
(18):
10538-44
-
Human immunodeficiency virus, type 1 protease substrate specificity is limited by interactions between substrate amino acids bound in adjacent enzyme subsites.
Ridky TW,
Cameron CE, Cameron J, Leis J, Copeland T, Wlodawer A, Weber IT, Harrison RW.
J Biol Chem.
1996;
271
(9):
4709-17
-
Development of drug resistance to HIV-1 protease inhibitors.
Ridky T,
Leis J.
J Biol Chem.
1995;
270
(50):
29621-3
Help